What should leadership do in the first 72 hours after receiving an FDA Form 483?

Leadership should resist the urge to begin drafting immediately. The first priority is to determine what FDA may be testing through each observation, reconstruct the evidence chain, identify affected products and systems, and establish clear ownership. A disciplined triage should distinguish immediate correction, interim control, root-cause work, CAPA, retrospective review, and longer-term remediation. The response becomes stronger when the organization first builds an evidence map, risk map, ownership map, and remediation logic rather than treating the Form 483 as a writing exercise.